Education
About Us
Working with TipRanks
Follow Us
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
Dose Level (Dl)1, Dl2, Dl3, Dl4, Dl5
Advanced Solid Tumors
Phase I
Recruiting
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
May 28, 2025
―
K0706
Early Parkinson Disease
Phase II
Terminated
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
Aug 18, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sun Pharma Advanced Research Co. Ltd. (SPARC) have in its pipeline
SPARC is currently developing the following drugs: Dose Level (Dl)1, Dl2, Dl3, Dl4, Dl5, K0706. These drug candidates are in various stages of clinical development as the company works toward FDA approval.